1. Home
  2. Analysis
  3. Nubeqa
  4. Weight-increased

Nubeqa and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Nubeqa (darolutamide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Orgovyx, and have Prostate cancer.

The phase IV clinical study analyzes which people have Weight increased when taking Nubeqa. It is created by eHealthMe based on reports of 1,495 people who have side effects when taking Nubeqa from the FDA, and is updated regularly.

What is Nubeqa?

Nubeqa has active ingredients of darolutamide. eHealthMe is studying from 1,499 Nubeqa users. Check the latest studies of Nubeqa.

What is Weight increased?

Weight increased is found to be associated with 2,886 drugs and 3,951 conditions by eHealthMe. Check the latest studies of Weight increased.

On Jul, 13, 2026

1,495 people reported to have side effects when taking Nubeqa.
Among them, 12 people (0.8%) have Weight increased.

Could Nubeqa cause Weight increased?

Among these 12 people:

How long have people been on Nubeqa when they have Weight increased? *

  • < 1 month: 80 %
  • 1 - 6 months: 20 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Weight increased when taking Nubeqa? *

  • female: 0.0 %
  • male: 100 %

What is the age of people who have Weight increased when taking Nubeqa? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 9.09 %
  • 60+: 90.91 %

What are other drugs people take besides Nubeqa? *

  1. Orgovyx: 2 people, 16.67%
  2. Valsartan: 1 person, 8.33%
  3. Tresiba: 1 person, 8.33%
  4. Tamsulosin: 1 person, 8.33%
  5. Synthroid: 1 person, 8.33%
  6. Omeprazole: 1 person, 8.33%
  7. Metformin: 1 person, 8.33%
  8. Gabapentin: 1 person, 8.33%
  9. Eligard: 1 person, 8.33%
  10. Atenolol: 1 person, 8.33%

What are other side effects people have besides Weight increased? *

  1. Weakness: 3 people, 25.00%
  2. Ascites (accumulation of fluid in the abdominal cavity): 3 people, 25.00%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 25.00%
  4. Pleural Effusion (water on the lungs): 3 people, 25.00%
  5. Cardiac Failure Congestive: 3 people, 25.00%
  6. Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 25.00%
  7. Discomfort: 3 people, 25.00%
  8. Fatigue (feeling of tiredness): 3 people, 25.00%
  9. Generalised Oedema (swelling all over the body): 3 people, 25.00%
  10. Insomnia (sleeplessness): 3 people, 25.00%

What are the existing conditions these people have? *

  1. Prostate Cancer: 6 people, 50.00%
  2. Cardiac Failure Chronic: 3 people, 25.00%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nubeqa and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nubeqa:

Weight increased treatments and more:

How severe was Weight increased and when was it recovered:

Expand to all the drugs that have ingredients of darolutamide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nubeqa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Browse all the conditions that are associated with Weight increased:

How the study uses the data?

The study uses data from the FDA. It is based on darolutamide (the active ingredients of Nubeqa) and Nubeqa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.